🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 68619K105 (prev. 68619K204 )
- Market Cap
- Micro Cap
Business: Orgenesis, Inc. is a vertically-integrated biopharmaceutical company with unique expertise and experience in cell therapy development and manufacturing. Through its Israeli subsidiary, Orgenesis Ltd., Orgenesis is a pioneer in the development of technology designed to successfully reprogram human liver cells into glucose-responsive, fully functional, Insulin Producing Cells (IPCs).
Company Contact
- CEO
- Vered Caplan
- CFO
- Victor Miller
- Headquarters
- 20271 Goldenrod Lane, Germantown, MD 20876
- Phone
- 480-659-6404
- Investor Relations
- David K. Waldman, Crescendo Comunications, LLC. · 212-671-1020 · orgs@crescendo-ir.com